Assistant Professor
Neuromuscular Specialist

College of Medicine
Department of Neurology

395 W. 12th Ave., 7th Floor
Columbus, OH 43210
614-293-6953
Amro.Stino@osumc.edu

Research Interests

  • Autoimmune peripheral neuropathy
  • Painful peripheral neuropathy
  • Hereditary peripheral neuropathy
  • Immunotherapies in neuromuscular disease

Current Research

Stino AM, Smith BE. Invited Review: The Spinal Accessory and Hypoglossal Nerves – Neurophysiologic Evaluation in the Outpatient Setting. Journal of Clinical Neurophysiology (in submission).

Stino AM, Iyadurai SJ. Dynamin-2 myopathy with electrical but not clinical myotonia and cold induced decrement. Muscle & Nerve (in submission, pending edits).

Lawson V, Grewal J, Hackshaw K, Mongiovi P, Stino AM.  Pain Characteristics do not Distinguish Fibromyalgia Patients with and without Small Fiber Neuropathy. Muscle & Nerve (in submission, pending review)

Prior D, Nurre E, Roller S, Kline D, Panara R, Stino AM, Davis J, Freimer ML, Arnold WD. Infections and the relationship to treatment in neuromuscular autoimmunity. Muscle & Nerve (in submission, pending review)

Rai W, Olcese V, Stino AM. Non-Hodgkin’s Lymphoma Masquerading as Purportedly Idiopathic or Genetic Recurrent Brachial Plexitis. Muscle & Nerve (in submission, pending review).

Stino AM, Efebera Y, Lorusso S, ElSheikh B, Hoyle C, Benson DM, Rosko A, Hofmeister CC.  Lenalidomide in Anti-MAG Neuropathy – A Feasibility Study.

Stino AM, Atway S, Anthony M, Kissel J, Kline D. Are Bedside Foot Measures able to identify High Arch patients with and without CMT?

Stino AM, Sadat Hosseiny Z, Saba K, Arnold WD. The clinical utility of serologic findings in GBS.

Lisak RP, Shaman K, Stino A, Prieto P. Correlation between Creatine Kinase levels and Neuromyelitis Optica.


Multi-Center and Drug-Sponsored Studies

PAREXEL       start date pending
CIDP01 (PXL226489): A Multicenter, Randomized, Subject-Blind, Investigator-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of UCB7665 in Subjects with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Phase 2A

NeuroNEXT Network & National Institute of Neurological Disorders and Stroke (NINDS)
Topiramate for Cryptogenic Sensory Peripheral Neuropathy        start date pending
Role: Site Principal Investigator

GBS/CIDP Foundation International                                01/15/2015-1/31/2018
International GBS Outcome Study
Role: Site Principal Investigator

PCORI#CER-1306-02496     07/01/2014-03/31/2017
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Role: Site Co-investigator

Pharm: Pharnext SA-CLN-PXT3003-02                           12/01/2015-12/01/2017
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)
Role: Site Principal Investigator

Education
MD: Wayne State University School of Medicine

Postgraduate Training
Residency: Adult neurology, Wayne State University – Detroit Medical Center
Residency: Preliminary year medicine, St. Joseph Mercy Health System
Fellowship: Electromyography (EMG) fellow with neuromuscular training, Mayo Clinic, Arizona

Honors
Reviewer, JAMA Neurology
Reviewer, Journal of Neuroimmunology

CV
PubMed articles

Subscribe. Get just the right amount of health and wellness in your inbox.